Delivery Order SPE2DE24D0013-SPE2D625F1RWJ
- Not listed
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $5,440 to Cepheid Inc. on August 25, 2025, for the supply of COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic solutions. This firm fixed-price delivery order, which is not set-aside designated, is scheduled for completion by September 2, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. The award represents a continuation of Cepheid's established role...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,488 firm fixed-price delivery order to Cepheid Inc. on July 30, 2025, for SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) diagnostic solutions. The delivery order, which carries an ultimate completion date of August 13, 2025, will be performed at Cepheid's headquarters in Sunnyvale, California. This award includes no set-aside designation and represents a near-term procurement from the Sunnyvale-based molecular...
- The U.S. Defense Medical Supply Chain awarded a $4,080 firm fixed-price delivery order to Cepheid Inc. on August 11, 2025, for diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV). This delivery order, with an ultimate completion date of August 18, 2025, carries no set-aside designation and represents a focused procurement of molecular diagnostic products or services from the Sunnyvale, California-based manufacturer. The award likely falls under...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain office, awarded a firm fixed-price delivery order valued at $8,840 to Cepheid Inc. on July 29, 2025, with an ultimate completion date of August 5, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). The contract carries no set-aside designation and will be...
- The Defense Department's Medical Supply Chain division awarded Cepheid Inc. a $17,952 firm fixed-price delivery order on August 4, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract is set to be completed by August 18, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This delivery order represents a continuation of the Defense Department's reliance on Cepheid's GeneXpert...
- The Defense Logistics Agency awarded a $2,992 delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, under contract 4568960202 for COVID-19, influenza, and respiratory syncytial virus (RSV) testing supplies and services. This firm fixed-price delivery order, with no set-aside designation, is scheduled for completion by August 15, 2025, and represents procurement of diagnostic reagents and related testing materials from Cepheid's GeneXpert...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $17,000 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 19, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus testing. The contract, designated as XPCOV2/FLU/RSV-10, has an ultimate completion date of August 26, 2025, and will be performed at Cepheid's headquarters in Sunnyvale, California. No small business set-aside was utilized for...
- The Defense Logistics Agency's Medical Supply Chain awarded a $30,678.60 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, for COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) testing solutions. The contract, which carries no set-aside designation, was executed on August 19, 2025, with an ultimate completion date of August 26, 2025. This delivery order is likely issued under one of Cepheid's existing Indefinite...
- The Defense Department's Medical Supply Chain awarded a $4,080 firm fixed-price delivery order to Cepheid Inc. on July 18, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, designated as XPCOV2/FLU/RSV-10, represents a delivery order with an ultimate completion date of July 25, 2025, and carries no set-aside designation. Work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $8,976 to Cepheid Inc. for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic solutions. The contract, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 2, 2025, and involves performance at Cepheid's facility in Sunnyvale, California. This delivery order carries no set-aside designation and represents a continuation of Cepheid's established role as a primary supplier of...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F1RWJDelivery Order
The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,080 to Cepheid Inc. for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic solutions. The delivery order, issued on August 22, 2025, with completion targeted for August 29, 2025, represents a continuation of the Medical Supply Chain's procurement of molecular diagnostic testing capabilities. Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced diagnostic systems and test kits, will perform the work at its California facility. This award carries no set-aside designation and reflects the government's ongoing reliance on Cepheid's GeneXpert diagnostic systems and associated reagents for infectious disease detection across federal healthcare systems. This delivery order likely draws from one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs, which has awarded the company two significant IDV agreements valued at $32.8 million and $2.5 million respectively, both supporting molecular diagnostic testing for conditions including COVID-19, influenza, RSV, and other infectious diseases. Cepheid's established partnerships with federal healthcare agencies, including the VA, Indian Health Service, and Defense Health Agency, position the company as a key supplier for diagnostic solutions within the federal medical supply chain. The modest delivery order value suggests targeted procurement of specific diagnostic materials or equipment maintenance services rather than major system deployment.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 8/22/25 |